It has been reported to promote non-small cell lung cancer (NSCLC) progression and metastasis by initiating forward feedback loop between PAFR and STAT3 [10], and contributes to the malignant development of esophageal squamous cell carcinoma by stimulating PI3K/AKT activation [11]. Here, STAT3 is linked to non-small cell lung carcinoma.